These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7481073)

  • 1. Cyclosporine-induced apoptosis in CD4+ T lymphocytes and computer-simulated analysis: modeling a treatment scenario for HIV infection.
    Huss R; Hoy CA; Ottinger H; Grosse-Wilde H; Deeg HJ
    Res Immunol; 1995 Feb; 146(2):101-8. PubMed ID: 7481073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of 4,5,6,7-tetrathiocino (1,2-b: 3,4-b') diimidazolyl-1,3,8,10-tetrasubstituted-2,9-dithiones (R4-todit).
    Pani A; Pinna E; Scintu F; Perra G; Corrias S; Trogu E; Deplano P; Colla PL
    Anticancer Res; 1998; 18(6A):4429-34. PubMed ID: 9891505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on allogeneic melanoma lysates in active specific immunotherapy.
    Mitchell MS
    Semin Oncol; 1998 Dec; 25(6):623-35. PubMed ID: 9865677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Skin cancers and environmental factors].
    Autier P
    Rev Med Brux; 1998 Sep; 19(4):A346-50. PubMed ID: 9805971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
    Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
    Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents.
    Onishi Y; Yamaura T; Tauchi K; Sakamoto T; Tsukada K; Nunome S; Komatsu Y; Saiki I
    Biol Pharm Bull; 1998 Jul; 21(7):761-5. PubMed ID: 9703264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein.
    Matsui T; Kageshita T; Ishihara T; Tomiguchi S; Takahashi M; Ono T
    Dermatology; 1998; 197(1):65-8. PubMed ID: 9693191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma.
    Gause BL; Sharfman WH; Janik JE; Curti BD; Steis RG; Urba WJ; Smith JW; Alvord WG; Longo DL
    Cancer Invest; 1998; 16(6):374-80. PubMed ID: 9679527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronucleus analysis in peripheral blood lymphocytes from melanoma patients treated with dacarbazine.
    Miele M; Bonassi S; Bonatti S; Martini E; Miglio L; Ottaggio L; Queirolo P; Sertoli M; Abbondandolo A
    Anticancer Res; 1998; 18(3B):1967-71. PubMed ID: 9677451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.
    Arber DA; Tamayo R; Weiss LM
    Hum Pathol; 1998 May; 29(5):498-504. PubMed ID: 9596274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UVB induces atypical melanocytic lesions and melanoma in human skin.
    Atillasoy ES; Seykora JT; Soballe PW; Elenitsas R; Nesbit M; Elder DE; Montone KT; Sauter E; Herlyn M
    Am J Pathol; 1998 May; 152(5):1179-86. PubMed ID: 9588887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of 5' region of human tenascin-R gene and characterization of its promoter.
    Gherzi R; Leprini A; Siri A; Zardi L
    DNA Cell Biol; 1998 Mar; 17(3):275-82. PubMed ID: 9539107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
    Lucchinetti CF; Kimmel DW; Lennon VA
    Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of squamous cell vulval cancer: a population based retrospective study of 411 cases.
    Rhodes CA; Cummins C; Shafi MI
    Br J Obstet Gynaecol; 1998 Feb; 105(2):200-5. PubMed ID: 9501787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
    Marchetti D; Nicolson GL
    J Investig Dermatol Symp Proc; 1997 Aug; 2(1):99-105. PubMed ID: 9487024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.
    Blom DJ; Goslings WR; De Waard-Siebinga I; Luyten GP; Claas FH; Gorter A; Jager MJ
    J Interferon Cytokine Res; 1997 Nov; 17(11):695-700. PubMed ID: 9402107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The large sample distribution of the weighted log rank statistic under general local alternatives.
    Ewell M; Ibrahim JG
    Lifetime Data Anal; 1997; 3(1):5-12. PubMed ID: 9384622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of IL-2 augments CTL response to human melanoma cells in vitro: immunological characterization of a melanoma vaccine.
    van Elsas A; Aarnoudse C; van der Minne CE; van der Spek CW; Brouwenstijn N; Osanto S; Schrier PI
    J Immunother; 1997 Sep; 20(5):343-53. PubMed ID: 9336741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.